| aOR (95% CI) |
---|---|
ITN use | |
 Participants | |
  Children | Ref |
  Women | 0.84 (0.69–1.00) |
 Wealth | |
  Lowest | Ref |
  Second | 1.90 (1.36–2.64) |
  Middle | 1.28 (0.93–1.77) |
  Fourth | 1.74 (1.26–2.41) |
  Top |  |
 Sampling round | |
  April–May’15 | Ref |
  June–July’15 | 0.75 (0.57–0.98) |
  August–September’15 | 0.63 (0.48–0.84) |
  October–November’15 | 0.44 (0.32–0.58) |
  January–March’16 | 0.53 (0.40–0.71) |
 Household size | 0.98 (0.94–1.03) |
Sought treatment | |
 Participants | |
  Children | Ref |
  Women | 0.52 (0.34–0.79) |
 Wealth | |
  Lowest | Ref |
  Second | 0.85 (0.41–1.76) |
  Middle | 0.87 (0.43–1.75) |
  Fourth | 1.29 (0.64–2.61) |
  Top | 1.67 (0.84–3.32) |
 Sampling round | |
  April–May’15 | Ref |
  June–July’15 | 1.01 (0.60–1.70) |
  August–September’15 | 0.87 (0.47–1.62) |
  October–November’15 | 0.76 (0.35–1.64) |
  January–March’16 | 0.80 (0.37–1.73) |
 Distance to health facility (km) | 1.06 (0.95–1.19) |
 Total people in household | 1.04 (0.92–1.17) |
3 or more IPTp-SP doses | |
 Age | 0.997 (0.99–1.00) |
 Education category | |
  None | Ref |
  Some primary | 0.54 (0.28–1.02) |
  Completed primary or some secondary | 0.90 (0.34–2.40) |
  Completed secondary | 0.47 (0.05–4.63) |
 Wealth quintile | |
  Lowest | Ref. |
  Second | 1.75 (0.70–4.41) |
  Middle | 1.26 (0.50–3.17) |
  Fourth | 1.58 (0.64–3.90) |
  Top | 1.47 (0.53–4.09) |
 Distance to health facility (km) | 0.93 (0.79–1.09) |